4967
KOBAYASHI PHARMACEUTICAL CO.,LTD.
4967
KOBAYASHI PHARMACEUTICAL CO.,LTD.
¥ -
-
Track KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) issued, treasury and outstanding shares over time, split-adjusted, alongside annual share buyback amounts.
2025-12
2020 → 2025-12
No comparable period
2024-12
Each bar is the issued share count. Buybacks grow treasury shares; cancelling them shrinks the issued count itself.
Splits: 2016-07-01: 2-for-1 split (effective date)
※ 2016-12: 2-for-1 split. From this period, the earnings release reports post-split share counts (this can start before the effective date).
Split-adjusted restates earlier share counts on today's basis. As reported shows the figures in each earnings release, which cannot be compared across a split.
Some treasury share counts are filled from annual or quarterly reports where no earnings release exists.
Cash returned to shareholders each year: dividends paid plus share buybacks, with the total payout ratio ((dividends + buybacks) ÷ net income).
Periods without a reported amount show "—". This does not necessarily mean nothing was paid or repurchased.
Buybacks are the amount spent on repurchases; treasury shares later handed out (for example as stock compensation) are not deducted, except where a company reports a net figure. See Treasury share disposals below.
The ratio uses net income attributable to owners of the parent, for the latest five years. Loss-making years are not shown. Dividends are the cash paid during the year (including the prior year-end dividend), so the ratio may differ from the one a company publishes.
Buyback authorisations and the latest reported progress (TDnet)
Resolved 2023-11-07
Period: 2023-11-08 – 2023-11-08 · Off-auction trading (ToSTNeT)
自己株式の取得および自己株式立会外買付取引（ToSTNeT-3）による自己株式の買付けに関するお知らせ
Resolved 2022-11-01
Period: 2022-11-02 – 2023-03-24 · Off-auction trading (ToSTNeT)
自己株式の取得および自己株式立会外買付取引（ToSTNeT-3）による自己株式の買付けに関するお知らせ
No progress filed yet.
Resolved 2021-10-28
Period: 2021-11-01 – 2022-06-23 · —
自己株式取得に係る事項の決定に関するお知らせ
Resolved 2019-01-31
Period: 2019-02-01 – 2019-08-31 · —
自己株式取得に係る事項の決定に関するお知らせ
Resolved 2017-02-01
Period: — – 2017-06-23 · Open market
一般財団法人 小林製薬青い鳥財団の設立ならびに自己株式の処分及び自己株式の取得に関するお知らせ
Resolved 2016-08-25
Period: 2016-08-26 – 2016-12-22 · —
自己株式取得に係る事項の決定に関するお知らせ
Resolved 2015-10-29
Period: 2015-10-30 – 2016-03-24 · —
自己株式取得に係る事項の決定に関するお知らせ
Progress divides the latest reported cumulative total by the cap. The share of issued shares is the figure stated by the company.
"Status unknown" means no end date, completion filing or cap was found; it is not necessarily in progress.
A tender offer's announcement, amendments and execution are combined only when the later filing explicitly cites the earlier one.
Data as of 2026-09-30
Disclosures of treasury shares handed out for share-based pay, employee ownership plans, allotments or M&A (TDnet)
2017-06-13
Contribution to a trustAnnounced
第三者割当による自己株式の処分に関するお知らせ（詳細決定）Log in to view2017-05-30
| Date | Purpose | Recipient | Shares | Amount | Disclosure |
|---|---|---|---|---|---|
| 2017-06-13 | Contribution to a trustAnnounced | Trust | 850,000 | ¥850000 | 第三者割当による自己株式の処分に関するお知らせ（詳細決定）Log in to view2017-05-30 |
"Announced" marks disposals without a matching completion notice; many companies do not publish one. When a completion notice matches on date, shares and purpose, the announcement is omitted.
Period-end treasury share counts already reflect these disposals; they are not calculated by adding these figures.
As reported in each earnings release
2023-12
2022-12
2016-122-for-1 split
| Fiscal year | Issued | Treasury | Outstanding | Buybacks | Dividends paid | Source |
|---|---|---|---|---|---|---|
| 2025-12 | 78,050,000 | 3,711,236 | 74,338,764 | — | ¥7.7B | Report |
| 2024-12 | 78,050,000 | 3,711,181 | 74,338,819 | ¥0 | ¥7.5B | Report |
| 2023-12 | 78,050,000 | 3,711,086 | 74,338,914 | ¥12.0B | ¥7.2B | Report |
| 2022-12 | 78,050,000 | 2,036,086 | 76,013,914 | ¥14.1B | ¥6.5B | Report |
| 2021-12 | 82,050,000 | 4,314,084 | 77,735,916 | ¥3.9B | ¥6.3B | Report |
| 2020-12 | 82,050,000 | 3,886,911 | 78,163,089 | ¥0 | ¥5.8B | Report |
| 2019-12 | 82,050,000 | 3,886,837 | 78,163,163 | ¥8.0B | ¥5.3B | Report |
| 2018-12 | 82,050,000 | 2,977,337 | 79,072,663 | — | ¥4.8B | Report |
| 2017-12 | 82,050,000 | 3,102,937 | 78,947,063 | ¥5.1B | ¥4.3B | Report |
| 2016-122-for-1 split | 85,050,000 | 6,257,437 | 78,792,563 | ¥8.1B | ¥3.9B | Report |
† Filled from annual or quarterly reports for periods without an earnings release.
For dividends per share and payout ratios, see Dividends.